Advertisement
Advertisement
U.S. markets close in 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6229-0.0159 (-2.49%)
As of 03:29PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.6388
Open0.6388
Bid0.6203 x 2200
Ask0.6388 x 900
Day's Range0.6101 - 0.6450
52 Week Range0.2600 - 2.7900
Volume73,175
Avg. Volume3,994,567
Market Cap15.16M
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-8.2190
Earnings DateNov 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACOR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acorda Therapeutics, Inc.
    ACOR: Lowering target price to $0.64ACORDA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $0.635200; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 years agoArgus Research
View more
Advertisement
Advertisement